Summit, AstraZeneca Discuss $15 Billion Cancer Drug Deal
Summit Therapeutics conducts advanced talks with AstraZeneca about a possible partnership worth up to $15 billion according to sources who...
JPMorgan Halves Stablecoin Growth Forecast to $500 Billion
JPMorgan reduced its stablecoin market growth predictions to $500 billion for 2028 which represents half of their initial optimistic forecast....
Microsoft to Cut Nearly 4% of Staff Amid AI Costs
Microsoft will eliminate about 4% of its worldwide staff because its extensive artificial intelligence investments have led to significant cost...
Stock Market Outlook Clouded by Tariffs, Earnings Uncertainty
The S&P 500 started its second half of 2025 at historic market peaks yet experts predict upcoming market challenges will...
Tesla Slides as Trump-Musk Clash Rattles Investors
Tesla stock prices fell by more than 5% on Tuesday while investors became increasingly concerned about the ongoing public dispute...
U.S. Warns Higher Tariffs Still Possible After July 9
The United States will impose significant tariff increases on countries that fail to complete trade agreements before July 9 according...
U.S., Canada Resume Trade Talks After Digital Tax Scrapped
The United States will start trade talks with Canada again after Ottawa removed its digital services tax plan for American...
Nike Surges on Tariff Strategy, Brand Revival Progress
Nike stock prices surged 13.3% during Friday trading after the company revealed its plan to decrease Chinese manufacturing exposure and...
Jobless Claims Dip, But Long-Term Unemployment Creeps Up
The number of new U.S. jobless claims decreased during the last week but continuing claims data indicates that unemployed workers...
UK Scrutinizes Boeing’s Spirit Deal for Competition Risks
The British antitrust authority is conducting an assessment of Boeing's $4.7 billion acquisition of Spirit AeroSystems because it was spun...
© 2025 Newsweek U.S. All rights reserved.
